Alvotech And Teva Announce U.S. Approval Of SIMLANDI Injection : vimarsana.com

Alvotech And Teva Announce U.S. Approval Of SIMLANDI Injection

Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced that the U.S. FDA has approved SIMLANDI (adalimumab-ryvk) injection, as an interchangeable biosimilar to Humira.

Related Keywords

United States , Eric Hughes , Robert Wessman , Teva Pharmaceutical Industries Ltd , Teva Pharmaceuticals , Teva Pharmaceutical Industries , Chief Medical Officer , Fda , Eva , Lvotech , Imlandi ,